This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Edwards case tests significance of pipeline in US merger monopoly suits

By Ilana Kowarski ( October 29, 2025, 18:37 GMT | Comment) -- Medical device creators Edwards Lifesciences and JenaValve Technology face a US Federal Trade Commission merger challenge that could emerge as a key test of how much weight courts will give to products still in development when analyzing merger monopolization claims.Medical device creators Edwards Lifesciences and JenaValve Technology face a merger challenge from the US Federal Trade Commission that is emerging as a key test of how much weight courts will give to pipeline products — innovations still in development — when analyzing merger monopolization claims....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login